Pia S Pannaraj
Overview
Explore the profile of Pia S Pannaraj including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
81
Citations
2578
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Leland S, Zambrano L, Staffa S, McNamara E, Newhams M, Halasa N, et al.
J Infect Dis
. 2025 Jan;
PMID: 39812486
Background: Pediatric respiratory syncytial virus (RSV)-related acute lower respiratory tract infection (LRTI) commonly requires hospitalization. The Clinical Progression Scale Pediatrics (CPS-Ped) measures level of respiratory support and degree of hypoxia...
2.
Domachowske J, Wahlby Hamren U, Banu I, Baronio R, Basavaraju B, Koen A, et al.
Pediatrics
. 2024 Sep;
154(4).
PMID: 39257380
Background And Objectives: Immunocompromised children may have increased risk for severe respiratory syncytial virus (RSV) lower respiratory tract infection (LRTI), potentially leading to prolonged hospitalization, intensive care, and death. The...
3.
Chwa J, Shin Y, Lee Y, Fabrizio T, Congrave-Wilson Z, Cheng W, et al.
J Appl Lab Med
. 2024 Sep;
9(6):927-937.
PMID: 39246012
Background: Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) variants demonstrate predilection for different regions of the respiratory tract. While saliva-based reverse transcription-polymerase chain reaction (RT-PCR) testing is a convenient, cost-effective alternative...
4.
Parker R, Le J, Villa M, Luong A, Lin T, Lee Y, et al.
Int J Cancer
. 2024 Jul;
155(12):2190-2200.
PMID: 39005114
Little is known about the efficacy of COVID-19 vaccines during acute lymphoblastic leukemia therapy (ALL); data for COVID-19 vaccine immune responses in pediatric leukemia remain sparse. We conducted a single...
5.
Chwa J, Kim M, Lee Y, Cheng W, Shin Y, Jumarang J, et al.
Viruses
. 2024 Jun;
16(6).
PMID: 38932145
Mucosal immunity may contribute to clearing SARS-CoV-2 infection prior to systemic infection, thereby allowing hosts to remain seronegative. We describe the meaningful detection of SARS-CoV-2-specific nasal mucosal antibodies in a...
6.
Zambrano L, Newhams M, Simeone R, Payne A, Wu M, Orzel-Lockwood A, et al.
MMWR Morb Mortal Wkly Rep
. 2024 Apr;
73(15):330-338.
PMID: 38635481
Pediatric COVID-19 vaccination is effective in preventing COVID-19-related hospitalization, but duration of protection of the original monovalent vaccine during SARS-CoV-2 Omicron predominance merits evaluation, particularly given low coverage with updated...
7.
Zambrano L, Newhams M, Simeone R, Fleming-Dutra K, Halasa N, Wu M, et al.
Pediatr Infect Dis J
. 2023 Dec;
43(3):242-249.
PMID: 38145397
Background And Objectives: In June 2022, the mRNA COVID-19 vaccination was recommended for young children. We examined clinical characteristics and factors associated with vaccination status among vaccine-eligible young children hospitalized...
8.
Kim M, Cheng W, Congrave-Wilson Z, Marentes Ruiz C, Turner L, Mendieta S, et al.
J Pediatric Infect Dis Soc
. 2023 Nov;
13(1):91-99.
PMID: 38016076
Background: Characterization of longitudinal SARS-CoV-2-specific antibody responses in children following infection and vaccination is needed to inform SARS-CoV-2 vaccine policy decisions for children, which may differ from adults. Methods: We...
9.
10.
Simeone R, Zambrano L, Halasa N, Fleming-Dutra K, Newhams M, Wu M, et al.
MMWR Morb Mortal Wkly Rep
. 2023 Oct;
72(39):1057-1064.
PMID: 37874864
Infants aged <6 months are not eligible for COVID-19 vaccination. Vaccination during pregnancy has been associated with protection against infant COVID-19-related hospitalization. The Overcoming COVID-19 Network conducted a case-control study...